期刊
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
卷 440, 期 1, 页码 94-98出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbrc.2013.09.021
关键词
CopA3; Coprisin; Antimicrobial peptide; Enantiomeric peptide; Membrane-active mechanism
资金
- Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ008158]
In our previous study, coprisin, a 43-mer defensin-like peptide, was derived from the dung beetle, Copris tripartitus, and a 9-met CopA3 (monomer), truncated coprisin analog peptide, was designed. However, the antifungal effects of CopA3 are not known yet. In this study, the antifungal activity and mechanism of CopA3 were investigated and to develop a more effective antimicrobial peptide under physiological conditions, the enantiomeric D-CopA3 was designed. and D-CopA3 had a similar antifungal activity without chiral selectivity, and their activity was more potent than that of melittin used as a positive control. Furthermore, and D-CopA3 did not even show any hemolysis against human erythrocytes. Membrane studies using propidium iodide and bis-(1,3-dibutylbarbituric acid) trimethine oxonol [DiBAC(4)(3)], suggested that the antifungal effect of and D-CopA3 was due to the membrane-active mechanism, by contrast with coprisin possessing apoptotic mechanism without membrane permeabilization. Finally, the proteolytic resistance and antifungal activity of L- and D-CopA3 against trypsin was analyzed by HPLC and colony count assay. The results showed that only D-CopA3 maintained a potent antifungal activity despite the proteolytic condition. Therefore, this study suggests that D-CopA3 has potential as a novel antimicrobial agent. (C) 2013 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据